<div id="readability-page-1">We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. Twist Biosciences Corporation is one of the most promising stocks on our list. TheFly reported on December 15 that Barclays raised its price target for TWST from $37 to $39 while maintaining an Overweight rating, reflecting confidence in the company’s margin […]</div>

TWST

<p>我們最近整理了一份分析師認為的 7 只最具潛力的基因編輯股票名單。Twist Biosciences Corporation 是我們名單上最具潛力的股票之一。TheFly 在 12 月 15 日報道稱，巴克萊將 TWST 的目標股價從 37 美元上調至 39 美元，同時維持 “增持” 評級，反映了對公司利潤率的信心……</p>

新產品的發佈強化了 Twist Bioscience（TWST）的看漲理由